Dr. Michael James, Founder and CSO of Essential Biotechnology LLC was a guest on the Biz Connection radio show broadcast in the Milwaukee area last weekend. Dr. James discusses Essential’s award as SE Wisconsin Healthcare Innovator of the Year and their path as a preclinical stage therapeutics company. Listen here.
Essential Biotechnology was selected as a presenter in the Pitch Perfect Contest at MedCity INVEST, Four Seasons Chicago, May 17-18
In January 2017, a team from Essential Biotechnology was invited to present to the Wellcome Trust Translation Fund Committee in London, UK. Drs. Clarke and James gave an overview of Essential’s scientific and clinical development programs related to anti-CRR9 cancer therapeutics. The team represented one of a handful of programs worldwide that were invited to present. Thanks to the Trust for their support of anti-CRR9 feasibility studies and the opportunity to visit them.
“A protein, CRR9, serves as a nexus for tumor cell survival. It’s located on the cell surface, making it an accessible drug target. By developing antibodies to the CRR9 protein, Essential Biotechnology has devised a method to kill therapy-resistant tumors.” – Jayson Kurfis
See the article here.
Essential Biotech is one of 27 companies out of 206 applications to be chosen as finalists in the Wisconsin Governor’s Business Plan Contest. Finalist entries range from social innovations to healthcare. A “diligent dozen” will present in the final competition for top prize at the Wisconsin Entrepreneur’s Conference in June.
Finalists named for Governor’s Business Plan Contest
Essential Biotechnology LLC is proud to be among the six finalists in the LES Foundation International Business Plan Competition. The six finalists were from the United States, Canada, Uganda, and Columbia and were chosen from business plan entries from around the world.
See the media release here:
Molecular Cancer Therapeutics, Online First March 3, 2016 ”
“Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.”
Essential Biotechnology is proud to be among the 53 semifinalists for the 2016 Wisconsin Governor’s Business Plan Contest. Entries will be made available to the Wisconsin Angel Network of accredited investors. Subsequent rounds will determine the dozen contestants to give live presentations at he Wisconsin Entrepreneurs’ Conference in Madison, WI on June 7.